Nyrada
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
L 4/828 Pacific Hwy Se 3, Gordon, New So...Phone Number
+61 290531990Website
www.nyrada.comRevenue
<$5 MillionStock Symbol
NYRIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Nyrada
Nyrada is a pre-clinical stage biotechnology company focused on developing novel small molecule drugs to address cardiovascular, neurodegenerative, and chronic inflammatory diseases. The company aims to become a high-growth bio-pharmaceutical entity specializing in drug discovery and early-stage development, particularly targeting areas with significant unmet clinical needs. Nyrada's current drug development programs include a PCSK9 inhibitor for high LDL-cholesterol, a neuroprotectant for stroke and traumatic brain injury, a treatment for pain from peripheral nerve damage, and a drug for autoimmune diseases like psoriasis. Their innovative approach centers around the benzopyran molecular scaffold to create effective and well-tolerated therapies.Explore more
Nyrada Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nyrada your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Nyrada launches new products
Click to see if Nyrada had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Nyrada has new funding data
Congratulate Masked Content for being promoted to Masked Content at Nyrada
Check if Nyrada has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Nyrada, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nyrada recently announced quarterly report
Check out if Nyrada is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Nyrada as Masked Content
Find 3 more new buyers
Compare Similar Companies to Nyrada
Compare insights from companies similar to Nyrada, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nyrada is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nyrada is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nyrada.
Nyrada financials insights
Gather financial insights about Nyrada, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Stock Offering
$11M
Nyrada Tech Stack
A closer look at the technologies used by Nyrada
Most Recent Scoops
Person-Based
Events
Person-Based
Stake & Stock Ownership, Finance
Person-Based
Stake & Stock Ownership, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Nyrada
Sign Up For FreeTo access detailed company insights
Nyrada is a pre-clinical stage biotechnology company focused on developing novel small molecule drugs to address cardiovascular, neurodegenerative, and chronic inflammatory diseases. The company aims to become a high-growth bio-pharmaceutical entity specializing in drug discovery and early-stage development, particularly targeting areas with signif... Read More
